Efficacy of dexamethasone treatment for patients with the acute respiratory distress syndrome caused by COVID-19: study protocol for a randomized controlled superiority trial

BACKGROUND: There are no specific generally accepted therapies for the coronavirus disease 2019 (COVID-19). The full spectrum of COVID-19 ranges from asymptomatic disease to mild respiratory tract illness to severe pneumonia, acute respiratory distress syndrome (ARDS), multisystem organ failure, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Villar, Jesús, Añón, José M., Ferrando, Carlos, Aguilar, Gerardo, Muñoz, Tomás, Ferreres, José, Ambrós, Alfonso, Aldecoa, César, Suárez-Sipmann, Fernando, Thorpe, Kevin E., Jüni, Peter, Slutsky, Arthur S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429135/
https://www.ncbi.nlm.nih.gov/pubmed/32799933
http://dx.doi.org/10.1186/s13063-020-04643-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429135/
https://www.ncbi.nlm.nih.gov/pubmed/32799933
http://dx.doi.org/10.1186/s13063-020-04643-1

Ejemplares similares